Kurume, Japan

Akihiko Yoshimura

This inventor holds 2 USPTO granted patents. Top assignee: Schering Corporation. Active years: 2003-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akihiko Yoshimura. Retrieved from https://idiyas.com/inventor/akihiko-yoshimura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Akihiko Yoshimura: Innovator in Chemokine Research

Introduction

Akihiko Yoshimura is a notable inventor based in Kurume, Japan. He has made significant contributions to the field of chemokine research, holding a total of 2 patents. His work focuses on novel reagents derived from mammalian chemokines, which have important implications in diagnostics and therapeutic applications.

Latest Patents

Yoshimura's latest patents include innovative developments in mammalian chemokine reagents. These patents describe a novel CC chemokine sourced from mammals, along with related reagents such as purified proteins, specific antibodies, and nucleic acids encoding the chemokine. Additionally, a chemokine receptor is provided, along with methods for utilizing these reagents and diagnostic kits.

Career Highlights

Akihiko Yoshimura is currently associated with Schering Corporation, where he continues to advance his research in chemokines. His work has garnered attention for its potential applications in medical diagnostics and treatment strategies.

Collaborations

Yoshimura has collaborated with notable colleagues, including Daniel J Dairaghi and Takahiko Hara, contributing to the advancement of research in his field.

Conclusion

Akihiko Yoshimura's contributions to chemokine research exemplify the impact of innovative thinking in the medical field. His patents and ongoing work continue to pave the way for advancements in diagnostics and therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…